extrachillimegawaysslot| Financial report express: Jinhao Medical's net profit for the first quarter of 2024 was 867,800 yuan

On April 26, Jinhao Medical, a listed company with A shares, released its first-quarter results report in 2024. Of which, the net profit is 86.Extrachillimegawaysslot780,000 yuan, down 92.26% from the same period last year.

According to the comprehensive operation and follow-up analysis of more than 1200 financial indicators of its financial data in the current period and the past five years, according to the financial diagnosis model of flush (300033), the overall financial situation of Jinhao Medical Group in the past five years is lower than the industry average. Specifically, the operating capacity is average.

Net profit was 867800 yuan, down 92.26% from the same period last year.

In terms of revenue and profit, the company achieved total operating income of 36.133 million yuan during the reporting period, down 39.14% from the same period last year, and net profit of 867800 yuan, down 92.26% from the same period last year.

In terms of assets, during the reporting period, the total assets at the end of the period were 421 million yuan and the accounts receivable were 13.3589 million yuan.ExtrachillimegawaysslotIn terms of cash flow, the net cash flow generated by business activities was 5.8357 million yuan, and the cash received from the sale of goods and services was 34.5892 million yuan.

There are five financial risks

According to the relevant financial information released by Jinhao Medical, there are five financial risks in the company, as follows:

The average year-on-year growth rate of performance deduction of non-net profit is-18.92%, and the growth of the company is poor. The average year-on-year growth rate of revenue is-1.23%, and the company's growth ability is very weak. The average year-on-year growth rate of net profit is-13.66%, and the growth of the company is very low. Revenue in the growth period decreased by 39.14% compared with the same period last year, with a higher decline in revenue. The operating profit of the growth period decreased by 97.13% compared with the same period last year, and the profit dropped greatly.

Overall, the overall financial situation of Jinhao Medical is lower than the industry average, with a current total score of 1.31, ranking low among 126 companies in the medical device industry. Specifically, the operating capacity is average.

The scores of the indicators are as follows:

Index type previous period score ranking evaluation profitability 2.660.99102 lower growth ability 4.230.24121 weaker cash flow 0.652.5862 still available asset quality 2.462.0675 still serviceable ability 2.821.4790 general total score 2.681.31110 lower than industry average

On the large model of financial diagnosis of flush

The flush financial diagnosis model calculates the company's financial scores, highlights and risks based on the company's latest and previous financial data and industry conditions, reflecting the disclosed financial position of the company, but not the forecast of the future financial position. The financial score range is 0-5. The higher the score, the better the financial situation and the greater the value of the medium-and long-term investment. In the financial highlights and risk reviews, the five-year average of the indicators related to the "average" keyword, and the latest reporting period data without the "average" keyword. All the above information is based on artificial intelligence algorithm, for reference only, does not represent flush financial point of view, investors operate accordingly, at their own risk.

Learn more about the company's stock diagnostic information >